Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pudilan oral liquid
- Development stage
- Unknown
- Lead developer
- Jichuan Pharmaceutical Group
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Pudilan oral liquid (also known as Pudilan Xiaoyan oral liquid) is a widely used commercial Traditional Chinese Medicine (TCM) / Chinese patent medicine in China. It is prepared from four cold-natured herbs: *Scutellaria baicalensis* (Huangqin), *Isatis indigotica* (Banlangen), *Corydalis bungeana* (Dihuding), and *Taraxacum mongolicum* (Pugongying). Pudilan oral liquid possesses heat-clearing, detoxifying, anti-inflammatory, and antibacterial properties. It is clinically indicated for the treatment of inflammatory and infectious conditions such as pharyngitis, tonsillitis, mumps, and upper respiratory tract infections. Additionally, it has been evaluated in clinical trials for pediatric COVID-19.
- Brand names
- Pudilan Xiaoyan Oral Liquid
- Other names
- PDLPudilan antiphlogistic oral liquidPudilan Xiaoyan KoufuyePudilan Xiaoyan oral liquid
02
Targets
ACE2 (Angiotensin-converting enzyme 2)TLR3 (Toll-like receptor 3)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)MYD88 (Myeloid differentiation primary response protein MyD88)RK (Ribokinase)TLR4 (Toll-like receptor 4)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)
Beyond the preview
Go deeper on Pudilan oral liquid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pudilan oral liquid.